Backed by Science. Built for Patients.
Clinical Trial Evidence
At mBIOTA Labs, we create clinically proven medical foods for patients with GI disorders - combining scientific rigor with empathy and respect for the patient experience.
As published in Clinical Gastroenterology and Hepatology
2023 Prospective Clinical Study
Effect, Tolerability, and Safety of Exclusive Palatable Elemental Diet in Patients with Intestinal Microbial Overgrowth
Our 2023 clinical trial of a 2-week course of mBIOTA in SIBO and IMO patients. The mBIOTA Elemental diet was tolerated by 100% of patients, eradicated overgrowth in 73% of patients overall and provided adequate relief from symptoms in 83% of patients.
Read published research featuring mBIOTA Elemental™ diet formula.
American College of Gastroenterology 2025
Elemental Diet Achieves Deep Remission in Dupilumab-Responsive EoE
American College of Gastroenterology 2025
mBIOTA Elemental Diet Does Not Promote Fungal Overgrowth and Reduce Candida
American College of Gastroenterology 2025
Elemental Diet Enables Outpatient Resolution of Partial Small Bowel Obstruction
American College of Gastroenterology 2025
Palatable Elemental Diet Reduces Visceral Fat Through Microbial and Hormonal Shifts
Digestive Diseases & Sciences 2025
Successful Outpatient Management of Partial Small Bowel Obstruction
Digestive Disease Week 2025
Reduction of Methane Levels Correlates with Fecal Abundance of M. smithii
FNM 2024
Maintained Visceral and Total Body Fat Loss Following Elemental Diet
American College of Gastroenterology 2024
Achieving Organoleptic Acceptability with Elemental Formula
Digestive Disease Week 2024
Compliance, Safety, and Effect of Exclusive Palatable Elemental Diet in Microbial Overgrowth
